SHANGHAI, China, Jan. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech , China’s premier provider of pharmaceutical R&D outsourcing services hosted its first supplier conference on January 28 in Shanghai, China.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
As a research-driven and customer-focused company, WuXi PharmaTech provides drug R&D outsourcing services to 80 global pharmaceutical and biotechnology companies. The company’s value chain is partially supported by a large number of qualified suppliers who provide WuXi PharmaTech with top- quality equipment and instruments, raw materials, reagents, consumables and other related products and services. The conference, with a theme of “Support Partner Success”, awarded suppliers who have helped WuXi PharmaTech to achieve greater efficiency and cost savings; it also provided a great venue to exchange ideas and new supply chain strategies that can positively impact financial and operational performance of WuXi PharmaTech. The half-day conference brought together about 120 representatives from over 70 selected supplier partners.
“The main purpose of WuXi PharmaTech’s supplier conference is to promote efficient, value-added supplier relationships with the collaborative partners that are fully aligned with our corporate values and business objectives. We also want our suppliers to better understand our unique business and operation model so that we can have the most efficient supply chain that is critical to improving our service quality and keeping our competitive advantage. With our recent acquisition of AppTec, a US-based biologics testing and manufacturing service company, WuXi PharmaTech will expand global sourcing operation and leverage global resources to further augment our service capability and capacity.” commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.
To recognize suppliers who have made remarkable contributions to the success of WuXi PharmaTech, the company presented Preferred Supplier Award to Sigma-Aldrich and Alfa Aesar for their excellent services and products. Suppliers are evaluated on quality of management system, quality of products, on-time delivery, customer service and cost.
“We are greatly honored to receive this award from WuXi PharmaTech, the leading and the largest drug R&D service company in China. Most of WuXi’s customers are also our customers and our vision ‘Enabling Science Globally through Innovation’ is consistent with that of WuXi’s ‘Transform Drug R&D Globally’,” commented Mr. Wilson Wang, Managing Director, Sigma-Aldrich Greater China after the conference, “We are very happy to become one of WuXi PharmaTech’s reliable partners.”
“I would like to thank WuXi PharmaTech for presenting this award to us. As a leading international manufacturer, supplier and distributor of fine chemicals, metals, and materials, we will continue to raise the levels of integrity, quality, and professionalism in providing our products and services to WuXi PharmaTech and assist it in achieving its strategic goal,” commented Ms. Deborah Groccott, General Manager, Avocado, UK of Alfa Aesar.
A Service Award was presented to Shanghai SILE to acknowledge its highly proactive and responsive services to WuXi PharmaTech.
About WuXi PharmaTech
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research- driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies with a broad and integrated portfolio of laboratory and research manufacturing services throughout the drug discovery and development process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, toxicology, pharmaceutical development and process development services; and research manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use. In 2007, its 80 customers included nine of the world’s top ten pharmaceutical companies by revenue. For more information, please visit: http://www.wuxipharmatech.com .
pr@pharmatechs.com
CONTACT: Sherry Shao, +86-21-5046-4002, or pr@pharmatechs.com
Web site: http://www.wuxipharmatech.com/
